Observational Study Evaluating Rituximab Use and Use of the Patient Alert Card in Participants Receiving Rituximab Infusion for a Non-Oncology Indication at Infusion Centers in Europe

Roche

Status: Completed

Conditions: Off-Label Use

Treatments: Biological: Rituximab

Study type: Observational

Funder types: Industry

Identifiers

NCT02654379

BA28478

Details and patient eligibility

About

This study is to characterize the indications for which rituximab is being used and to evaluate the use of the Patient Alert Card (PAC) in participants receiving the medication for non-oncology conditions at infusion centers. The study involves the retrospective chart review of rituximab users' medical records in non-oncology indications as well as a survey to collect information on participant characteristics, and will include questions about participant knowledge on the risk of infections, participant receipt and review of the PAC, and any actions the participant has taken as a result of receiving the PAC.

Enrollment: 1,408 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participant is in the center to receive an infusion for rituximab for a non-oncology indication during the study period
• Aged 18 years or older

Exclusion criteria

• Has previously already completed the rituximab survey
• Has participated in the past 12 months in a clinical trial in which rituximab was one of the treatments being evaluated.

Trial design

1,408 participants in 1 patient group

Cohort

Description:

Cohort consisting of participants who are in the center to receive an infusion for rituximab for a non-oncology indication.

Treatment:

Biological: Rituximab